香港生物科技公司 Prenetics 乘新冠疫情衝擊納斯達克
2022年5月20日 |
NIKKEI Asia |
投資對象
The content is available in English.
HONG KONG -- Biotech startup Prenetics, a COVID-19 test provider that helped soccer's Premier League resume matches, is set to go public Wednesday on the Nasdaq, making it Hong Kong's first unicorn to list.
